Actinium Pharmaceuticals Inc (ATNM)
8.69
-0.21
(-2.36%)
USD |
NYAM |
May 10, 13:53
Actinium Pharmaceuticals Cash from Investing (Quarterly): -0.011M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.011M |
| December 31, 2023 | 0.00 |
| September 30, 2023 | -0.03M |
| June 30, 2023 | -0.047M |
| March 31, 2023 | -0.076M |
| December 31, 2022 | -0.016M |
| September 30, 2022 | -0.073M |
| June 30, 2022 | -0.27M |
| March 31, 2022 | -0.007M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -0.068M |
| June 30, 2021 | -0.061M |
| March 31, 2021 | -0.004M |
| December 31, 2020 | -0.245M |
| September 30, 2020 | -0.008M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | -0.005M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | -0.008M |
| March 31, 2019 | -0.051M |
| December 31, 2018 | -0.0106M |
| September 30, 2018 | -0.0587M |
| June 30, 2018 | -0.0198M |
| March 31, 2018 | -0.007M |
| Date | Value |
|---|---|
| December 31, 2017 | -0.0013M |
| September 30, 2017 | -0.0068M |
| June 30, 2017 | -0.0084M |
| March 31, 2017 | -0.0083M |
| December 31, 2016 | -0.0172M |
| September 30, 2016 | -0.0013M |
| June 30, 2016 | -0.0139M |
| March 31, 2016 | -0.0774M |
| December 31, 2015 | -0.0208M |
| September 30, 2015 | -0.026M |
| June 30, 2015 | -0.001M |
| March 31, 2015 | 0.00 |
| December 31, 2014 | -0.0355M |
| September 30, 2014 | -0.0224M |
| June 30, 2014 | -0.1267M |
| March 31, 2014 | -0.0017M |
| December 31, 2013 | -0.0086M |
| September 30, 2013 | -0.0069M |
| June 30, 2013 | 0.00 |
| March 31, 2013 | -0.0011M |
| December 31, 2012 | -0.0005M |
| September 30, 2012 | -0.0007M |
| June 30, 2012 | 0.00 |
| March 31, 2012 | -0.0012M |
| December 31, 2011 | 0.025M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.27M
Minimum
Jun 2022
--
Maximum
Sep 2019
-0.0465M
Average
-0.0095M
Median
Cash from Investing (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -0.089M |
| Eli Lilly and Co | -1.178B |
| Cellectar Biosciences Inc | -0.2668M |
| Outlook Therapeutics Inc | -- |
| Bristol-Myers Squibb Co | -19.62B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.374M |
| Cash from Financing (Quarterly) | 14.77M |
| Free Cash Flow | -39.72M |
| Free Cash Flow Per Share (Quarterly) | -0.2648 |
| Free Cash Flow Yield | -16.84% |